WHO ICTRP trial
A randomized, double-blind, placebo-controlled study to evaluate the efficacy…
CTIS2023-504298-19-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2023-504298-19-00 |
|---|---|
| Public title | A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety deucravacitinib in patients with chronic hand eczema (investigator-sponsored research) |
| Scientific title | A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety deucravacitinib in patients with chronic hand eczema - DECIDE |
| Primary sponsor | Charite Universitaetsmedizin Berlin KöR |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use - (Phase IV): no |
| Countries | Germany |
| Conditions | Chronic Hand Eczema;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] |
| Interventions | Product Name: Matching placebo to IMP,Product Code: N/A,Pharmaceutical Form: N/A,Other descriptive name: N/A,Strength: N/A,Pharmaceutical form of the placebo: N/A,Product Name: SOTYKTU 6 mg film-coated tablets,Product Code… |
| Registration date | Jan 9, 2023 |
| Target size | 57 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: